Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Frailty in Older Adults: Evidence for a PhenotypeCohort Study · 2001 · 24,695 citations
2. 2Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung CancerRCT · 2018 · 3,722 citations
3. 3Comparison of 2 Frailty Indexes for Prediction of Falls, Disability, Fractures, and Death in Older WomenCohort Study · 2008 · 1,009 citations
4. 4Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta‐analysisMeta-Analysis · 2021 · 142 citations
5. 5Sarcopenia is poor risk for unfavorable short- and long-term outcomes in stage I non-small cell lung cancerOriginal Research · 2021 · 19 citations